SEC Form 4 · accession 0001144204-17-064152
ASSEMBLY BIOSCIENCES, INC. · ASMB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan Mahony
Director
Period of report
Dec 14, 2017
Accepted (ET)
Dec 18, 2017 · 5:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001426800
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $42.61 | Dec 14, 2017 | A | 20,000 | A | — | Dec 14, 2027 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The shares of common stock underlying the option will vest in equal annual installments on the first, second and third anniversaries of the grant date.